# Methylene Blue Treatment of Chronic Hepatitis B Virus Infection

> **NCT06887036** · PHASE2 · RECRUITING · sponsor: **Fondazione Epatocentro Ticino** · enrollment: 10 (estimated)

## Conditions studied

- Chronic HBV Infection

## Interventions

- **DRUG:** Methylene Blue

## Key facts

- **NCT ID:** NCT06887036
- **Lead sponsor:** Fondazione Epatocentro Ticino
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06887036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06887036, "Methylene Blue Treatment of Chronic Hepatitis B Virus Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06887036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*